Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has purchased 1,001,107 ordinary shares between May 11 and May 15, 2026, as part of its $250 million share repurchase program. The company has spent £83.0 million to date on repurchasing 6,388,695 shares, and intends to cancel these repurchased shares. Following these transactions and cancellations, Hikma Pharmaceuticals will have 215,497,758 ordinary shares in issue, with the total number of voting rights remaining the same.

Disclaimer*

UK 100

Latest directors dealings